株式会社極東書店トップ商品一覧Blood-Brain Barrier: Drug Delivery and Brain Pathology. Softcover reprint of the original 1st ed. 2001

商品詳細

Blood-Brain Barrier: Drug Delivery and Brain Pathology. Softcover reprint of the original 1st ed. 2001

Blood-Brain Barrier: Drug Delivery and Brain Pathology. Softcover reprint of the original 1st ed. 2001

・ISBN 978-1-4613-5141-2 paper EUR 49.99

¥13,361.- (税込) (※)価格はご注文時の参考価格となります。
納品価格につきましては書籍の入荷時点で確定となります。
版元の原価改定、外国為替の変動等により異なる場合がございますので、予めご了承下さい。

お気に入り
著者・編者Kobiler, David / Lustig, Shlomo / Shapira, Shlomo (eds.),
出版社 (Springer-Verlag New York Inc., US)
出版年月2012
ページ数434 pp.
言語ENG
ニュース番号<A05-37061>

解説

The vasculature of the central nervous system (eNS) is characterized by the existence of the blood-brain barrier (BBB), which can be regarded as both an anatomical and physiological phenomenon. The BBB is formed by a complex cellular system of endothelial cells, astroglia, pericytes, perivascular macrophages and a basal membrane, although the anatomic substrate of the BBB is the interendothelial tight junctions that form a continuous sealing. The BBB serves as an exquisitely controlled, functional gate to the eNS. It not only protects the brain from agents in the blood that could impair neurological function, but also controls the influx and efflux of numerous substances to maintain proper homeostasis and provide the brain with necessary nutrients. The structural and functional integrity of the BBB was shown to be dramatically altered during various diseases of the eNS, including neoplasia, ischemia, trauma, hypertension, inflammation and epilepsy. Recent years research has partially elucidated the mechanisms underlying the development of some of these brain disorders as well as the pathways used by different pathogens, like bacteria and viruses, to initiate eNS infections. The development of in vitro models of the BBB had instrumental role in the understanding of the involvement of the BBB in the pathogenesis of several eNS diseases. The intimate, functional association between the function of the brain and the activity of the BBB makes the later a target for pharmacological modulation that will expand the therapeutic possibilities for a range of neurological diseases.